Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Understand which fund covers more stocks between Total Market and Sp 500 Retirement and how this impacts diversification and potential returns.
28,617 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
The SpaceX IPO hype could pull even the most skeptical investors into ownership. This guide explains why even those a...
NVIDIA led the AI hardware rally, but the backbone of today’s AI deployments sits in memory and storage. This piece e...
Tariff rules matter to everyday prices and jobs. This article explains why failing renew USMCA would raise uncertaint...
Tenable’s stock jumped on Monday, marking a sharp continuation of a rally that started in the spring. This article di...
A long-running insurer broker, founded in 1941, has quietly raised its dividends for decades and now offers a compell...
The 2026 HousingWire Homebuilder Rankings broaden the field, adding new metrics that measure profitability and local ...
When a legend passes, we glimpse more than fame. This piece examines clive davis's money-minded approach to nurturing...
A long-awaited conversation with lasting impact on culture also carries financial lessons. This article breaks down h...
A booming corner of lending shows signs of stress as liquidity tightens and defaults rise, with potential spillovers ...
A high-profile investor recently revealed a sizable XRP ETF stake. This article breaks down what that means, how XRP ...
A quiet shift in the job market is reshaping housing and lending. This piece breaks down how the white-collar recessi...